🚀 VC round data is live in beta, check it out!
JMDC Valuation Multiples
Discover revenue and EBITDA valuation multiples for JMDC and similar public comparables like Indegene, Certara, Clover Health, GeneDx and more.
JMDC Overview
About JMDC
JMDC Inc is engaged in constructing and providing a medical database, offering PHR and other health promotion services, telemedicine such as diagnostic imaging, and providing digital solutions to dispensing pharmacies.
Founded
2002
HQ
Employees
178
Website
Financials (LTM)
EV
$2B
JMDC Financials
JMDC reported last 12-month revenue of $320M and EBITDA of $90M.
In the same LTM period, JMDC generated $182M in gross profit, $90M in EBITDA, and $47M in net income.
Revenue (LTM)
JMDC P&L
In the most recent fiscal year, JMDC reported revenue of $288M and EBITDA of $77M.
JMDC expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $320M | XXX | $288M | XXX | XXX | XXX |
| Gross Profit | $182M | XXX | $149M | XXX | XXX | XXX |
| Gross Margin | 57% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $90M | XXX | $77M | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 27% | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $47M | XXX | $50M | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 17% | XXX | XXX | XXX |
| Net Debt | — | — | $38M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
JMDC Stock Performance
JMDC has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
JMDC's stock price is $25.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.6% | XXX | XXX | XXX | $0.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJMDC Valuation Multiples
JMDC trades at 5.6x EV/Revenue multiple, and 20.0x EV/EBITDA.
EV / Revenue (LTM)
JMDC Financial Valuation Multiples
As of April 5, 2026, JMDC has market cap of $2B and EV of $2B.
Equity research analysts estimate JMDC's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
JMDC has a P/E ratio of 35.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 5.6x | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBITDA | 20.0x | XXX | 23.4x | XXX | XXX | XXX |
| EV/EBIT | 24.7x | XXX | 29.9x | XXX | XXX | XXX |
| EV/Gross Profit | 9.9x | XXX | 12.0x | XXX | XXX | XXX |
| P/E | 35.4x | XXX | 33.3x | XXX | XXX | XXX |
| EV/FCF | 134.9x | XXX | 21.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified JMDC Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
JMDC Margins & Growth Rates
JMDC's revenue in the last 12 month grew by 19%.
JMDC's revenue per employee in the last FY averaged $1.6M, while opex per employee averaged $0.5M for the same period.
JMDC's rule of 40 is 48% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
JMDC's rule of X is 78% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
JMDC Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Growth | 21% | XXX | 17% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 48% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 78% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 34% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
JMDC Public Comps
See public comps and valuation multiples for other Health Data & Analytics and Telemedicine & Virtual Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Indegene | XXX | XXX | XXX | XXX | XXX | XXX |
| Certara | XXX | XXX | XXX | XXX | XXX | XXX |
| Clover Health | XXX | XXX | XXX | XXX | XXX | XXX |
| GeneDx | XXX | XXX | XXX | XXX | XXX | XXX |
| CareDx | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JMDC M&A Activity
JMDC acquired XXX companies to date.
Last acquisition by JMDC was on XXXXXXXX, XXXXX. JMDC acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by JMDC
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJMDC Investment Activity
JMDC invested in XXX companies to date.
JMDC made its latest investment on XXXXXXXX, XXXXX. JMDC invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by JMDC
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout JMDC
| When was JMDC founded? | JMDC was founded in 2002. |
| Where is JMDC headquartered? | JMDC is headquartered in Japan. |
| How many employees does JMDC have? | As of today, JMDC has over 178 employees. |
| Who is the CEO of JMDC? | JMDC's CEO is Ryo Noguchi. |
| Is JMDC publicly listed? | Yes, JMDC is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of JMDC? | JMDC trades under 4483 ticker. |
| When did JMDC go public? | JMDC went public in 2019. |
| Who are competitors of JMDC? | JMDC main competitors are Indegene, Certara, Clover Health, GeneDx. |
| What is the current market cap of JMDC? | JMDC's current market cap is $2B. |
| What is the current revenue of JMDC? | JMDC's last 12 months revenue is $320M. |
| What is the current revenue growth of JMDC? | JMDC revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of JMDC? | Current revenue multiple of JMDC is 5.6x. |
| Is JMDC profitable? | Yes, JMDC is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of JMDC? | JMDC's last 12 months EBITDA is $90M. |
| What is JMDC's EBITDA margin? | JMDC's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of JMDC? | Current EBITDA multiple of JMDC is 20.0x. |
| What is the current FCF of JMDC? | JMDC's last 12 months FCF is $13M. |
| What is JMDC's FCF margin? | JMDC's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of JMDC? | Current FCF multiple of JMDC is 134.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.